Home > Cashflow Statement > BIOCON

BIOCON
Cashflow Statement

BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹448 Cr₹1,887 Cr₹1,525 Cr₹897 Cr₹983 Cr
Adjustment ₹2,921 Cr₹1,711 Cr₹2,356 Cr₹1,685 Cr₹1,245 Cr
Changes In working Capital ₹-1,132 Cr₹923 Cr₹-635 Cr₹-501 Cr₹-790 Cr
Cash Flow after changes in Working Capital ₹2,237 Cr₹4,521 Cr₹3,246 Cr₹2,081 Cr₹1,439 Cr
Cash Flow from Operating Activities ₹1,994 Cr₹4,061 Cr₹2,954 Cr₹1,853 Cr₹1,177 Cr
Cash Flow from Investing Activities ₹-2,082 Cr₹-234 Cr₹-1,005 Cr₹-14,282 Cr₹-1,699 Cr
Cash Flow from Financing Activities ₹-924 Cr₹-1,854 Cr₹-2,333 Cr₹13,049 Cr₹242 Cr
Net Cash Inflow / Outflow ₹-1,012 Cr₹1,973 Cr₹-383 Cr₹619 Cr₹-280 Cr
Opening Cash & Cash Equivalents ₹2,924 Cr₹920 Cr₹1,300 Cr₹654 Cr₹897 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ----₹34 Cr
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹199 Cr₹31 Cr₹2.90 Cr₹22 Cr₹3.30 Cr
Closing Cash & Cash Equivalent ₹2,112 Cr₹2,924 Cr₹920 Cr₹1,295 Cr₹654 Cr

Compare Cashflow Statement of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹67,045.9 Cr 0.3% -3.3% 16.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

0.3%

-3.3%

16.3%

SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses